We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Read MoreHide Full Article
In the latest close session, Albemarle (ALB - Free Report) was down 2.28% at $156.69. The stock's performance was behind the S&P 500's daily loss of 0.37%. On the other hand, the Dow registered a gain of 0.29%, and the technology-centric Nasdaq decreased by 1.33%.
Coming into today, shares of the specialty chemicals company had lost 6.55% in the past month. In that same time, the Basic Materials sector gained 3.31%, while the S&P 500 gained 2.02%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company is predicted to post an EPS of $3.08, indicating a 2700% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.48 billion, up 11.36% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.39 per share and revenue of $5.99 billion, which would represent changes of +1668.35% and +16.45%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 7.74% higher. Albemarle is holding a Zacks Rank of #1 (Strong Buy) right now.
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 12.94. Its industry sports an average Forward P/E of 15.51, so one might conclude that Albemarle is trading at a discount comparatively.
It's also important to note that ALB currently trades at a PEG ratio of 0.81. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified was holding an average PEG ratio of 1.15 at yesterday's closing price.
The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 73, placing it within the top 30% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, Albemarle (ALB - Free Report) was down 2.28% at $156.69. The stock's performance was behind the S&P 500's daily loss of 0.37%. On the other hand, the Dow registered a gain of 0.29%, and the technology-centric Nasdaq decreased by 1.33%.
Coming into today, shares of the specialty chemicals company had lost 6.55% in the past month. In that same time, the Basic Materials sector gained 3.31%, while the S&P 500 gained 2.02%.
Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company is predicted to post an EPS of $3.08, indicating a 2700% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.48 billion, up 11.36% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.39 per share and revenue of $5.99 billion, which would represent changes of +1668.35% and +16.45%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 7.74% higher. Albemarle is holding a Zacks Rank of #1 (Strong Buy) right now.
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 12.94. Its industry sports an average Forward P/E of 15.51, so one might conclude that Albemarle is trading at a discount comparatively.
It's also important to note that ALB currently trades at a PEG ratio of 0.81. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified was holding an average PEG ratio of 1.15 at yesterday's closing price.
The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 73, placing it within the top 30% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.